Shawn Levy, PhD

Shawn Levy is Chief Scientific Officer and SVP of Applications and leads a multidisciplinary team supporting applications development as well as external partnerships and collaborations.

Shawn has over 20 years of experience in genomic applications development and technology optimization, as well as operational management of research, development, and clinical testing programs. Prior to joining Element, Shawn was Chief Scientific Officer at Discovery Life Sciences and a faculty investigator at the HudsonAlpha Institute for Biotechnology. While at HudsonAlpha, Shawn developed a comprehensive genomics facility that has supported more than 5,200 projects from locations around the world. His laboratory raised more than $150M in extramural funding, culminating in the largest financial transaction in HudsonAlpha’s history when the assets of his research group were sold to Discovery Life Sciences. Before HudsonAlpha, Shawn was a faculty member at Vanderbilt University Medical Center in the Department of Biomedical Informatics and the Department of Molecular Physiology and Biophysics. He is an author or co-author of more than 200 peer-reviewed publications with over 45,000 citations.

Shawn has served on a variety of advisory, review, and oversight boards for public and private agencies around the world. He has been recognized as a technical and process improvement specialist in a variety of areas. He has been awarded two patents for his work and his research has appeared in a variety of media formats and been used in educational programs.

Shawn received his Ph.D. in Biochemistry from Emory University studying mouse models of mitochondrial disease. Originally from Lowell, MA, he adds to Element’s fine history of support for Boston sports.